Skip to contentUniversitywide | New Brunswick | RBHS | Newark | Camden | Online
Search result opens in new window

Rutgers University logoGo to Rutgers University site

Summer Undergraduate Research Fellowship

Ernest Mario School of Pharmacy

  • Home
  • Overview
  • Application
  • Activities
    • Research
    • Enrichment
  • Participants
    • SURF Participants 2022
    • SURF Participants 2021
    • SURF Participants 2020
    • SURF Participants 2019
    • SURF Participants 2018
    • SURF Participants 2017
    • Prior Years
  • Outcomes
    • Publications
    • Symposia
    • Presentations
    • Awards
    • SURFers in the News
    • Education
    • Support
  • News
  • Calendar
  • Gallery
    • SURF 2021
    • SURF 2020
    • SURF 2019
    • SURF 2018

Development and in-vitro evaluation of co-loaded berberine chloride and evodiamine ethosomes for treatment of melanoma

Posted March 6, 2020, in publications.

Development and in-vitro evaluation of co-loaded berberine chloride and evodiamine ethosomes for treatment of melanoma

Yoonsun Choi, SURF 2017

Post navigation

‹ Previous: Analysis of Stakeholder Engagement in the Public Comments of ICER Draft Evidence Reports
Next: Sex- and age-dependent effects of maternal organophosphate flame-retardant exposure on neonatal hypothalamic and hepatic gene expression ›

Admin

Copyright WordPress admin login page© Rutgers, The State University of New Jersey. All rights reserved.

Page last updated by L. Everett at 1:11 pm October 4, 2022.

This page was printed from http://surf.rutgers.edu/2020/03/development-and-in-vitro-evaluation-of-co-loaded-berberine-chloride-and-evodiamine-ethosomes-for-treatment-of-melanoma/ at 11:10 AM Saturday, April 1, 2023.